Wedbush Securities’s Trinity Biotech TRIB Stock Holding History

Wedbush Securities’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,800	Closed	-$31K	–	1018
2020 Q2	$31K	Buy	+2,800	New	+$21.3K	﹤0.01%	930
2019 Q1	–	Sell	-2,364	Closed	-$27K	–	953
2018 Q4	$27K	Sell	2,364 -890	-27%	-$13.7K	﹤0.01%	809
2018 Q3	$65K	Sell	3,254 -70	-2%	-$1.52K	0.01%	862
2018 Q2	$83K	Sell	3,324 -276	-8%	-$6.64K	0.01%	820
2018 Q1	$93K	Sell	3,600 -1,220	-25%	-$33.3K	0.01%	757
2017 Q4	$123K	Sell	4,820 -750	-13%	-$19.3K	0.02%	777
2017 Q3	$156K	Sell	5,570 -90	-2%	-$2.51K	0.02%	744
2017 Q2	$170K	Sell	5,660 -210	-4%	-$5.95K	0.02%	732
2017 Q1	$175K	Buy	5,870 +3,230	+122%	+$101K	0.02%	712
2016 Q4	$91K	Buy	+2,640	New	+$90.9K	0.01%	748

Other funds holding TRIB

HAIM

Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCM

Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Wedbush Securities's TRIB Position: Q3 2020 in Review

Wedbush Securities sold out of Trinity Biotech (TRIB) in Q3 2020, closing a stake of 2,800 shares — an estimated $31K sold.

Wedbush Securities first reported a position in TRIB in Q4 2016 and held it in 10 quarters. The position peaked at $175K in Q1 2017. 24 funds tracked by Wall St. Rank hold TRIB as of Q3 2020.

Wedbush Securities reported no remaining Trinity Biotech position as of Q3 2020 after selling out during the quarter.
Wedbush Securities sold 2,800 Trinity Biotech shares in Q3 2020, an estimated $31K.
Wedbush Securities first reported a position in Trinity Biotech in Q4 2016 and held it in 10 quarters.
Wedbush Securities's Trinity Biotech position peaked at $175K in Q1 2017.
24 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2020.

Based on Wedbush Securities's 13F filing for Q3 2020, filed 20 Oct 2020.